The global non-invasive ventilators market size accounted for USD 3.00 billion in 2024, grew to USD 3.19 billion in 2025 and is expected to be worth around USD 5.47 billion by 2034, registering a CAGR of 6.19% between 2024 and 2034. The North America non-invasive ventilators market size is calculated at USD 1.68 billion in 2024 and is estimated to grow at a CAGR of 6.29% during the forecast period.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Non-Invasive Ventilators Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Non-Invasive Ventilators Market Revenue and Volume, by Application, 2024-2034
8.1.1. Respiratory Distress Syndrome
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Asthma & COPD
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
8.1.3. Others
8.1.3.1. Market Revenue and Volume Forecast (2021-2034)
9.1. Non-Invasive Ventilators Market Revenue and Volume, by End User, 2024-2034
9.1.1. Ambulatory Surgical Centers
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Hospitals and Clinics
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1.3. Others
9.1.3.1. Market Revenue and Volume Forecast (2021-2034)
10.1. North America
10.1.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.1.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.1.3.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.1.4.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.2.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.2.3.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.2.4.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.2.5.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.2.6.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.3.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.3.3.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.3.4.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.3.5.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.3.6.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.4.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.4.3.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.4.4.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.4.5.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.4.6.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.5.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.5.3.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.5.4.2. Market Revenue and Volume Forecast, by End User (2021-2034)
11.1. ResMed Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Teleflex Incorporated
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Hamilton Bonaduz AG
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. HEYER Medical AG
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Respironics
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Airon Corporation
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Fisher & Paykel Healthcare
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Magnamed
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Medin Medical Innovations GmbH
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Mindray Medical International Limited
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample